PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
1213.73%
Some net income increase while CNQ is negative at -147.81%. John Neff would see a short-term edge over the struggling competitor.
6.11%
Some D&A expansion while CNQ is negative at -2.73%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
292.46%
Some yoy growth while CNQ is negative at -475.23%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
No Data
No Data available this quarter, please select a different quarter.
-41.66%
Negative yoy working capital usage while CNQ is 289.10%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-41.66%
Negative yoy usage while CNQ is 289.10%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
-72.45%
Negative yoy while CNQ is 70.93%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
13.66%
Operating cash flow growth at 75-90% of CNQ's 15.52%. Bill Ackman would recommend further refinements to match competitor’s CFO gains.
-4.79%
Both yoy lines negative, with CNQ at -20.81%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
-100.00%
Negative yoy acquisition while CNQ stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
We reduce yoy sales while CNQ is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-113.63%
We reduce yoy other investing while CNQ is 2438.17%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-32.86%
Both yoy lines negative, with CNQ at -8.00%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
100.00%
Debt repayment growth of 100.00% while CNQ is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
-79.29%
Both yoy lines negative, with CNQ at -46.11%. Martin Whitman suspects an environment or preference for internal financing over new equity in the niche.
95.12%
Buyback growth of 95.12% while CNQ is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.